Business Context and Reporting Period
Company: GlaxoSmithKline plc
Filing Type: Form 6-K (Report of Foreign Issuer)
Reporting Period: Six months ended June 30, 2005
Filing Date: July 29, 2005
This filing serves as a notice that GlaxoSmithKline plc published its 2005 Half Year Report results via advertisements in the Financial Times, the Daily Telegraph, and the Wall Street Journal. The full report is available on the company's website and at the UK Listing Authority's Document Viewing Facility.
Key Financial Metrics
The provided filing text does not contain specific financial data. It acts solely as a reference to the publication of the Half Year Report. Consequently, the following metrics are not available in this document:
- Revenue: Not provided in filing text.
- Profit: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide comparative data or details regarding material changes versus the prior comparable period. Investors must refer to the referenced Half Year Report advertisements for this information.
Guidance, Outlook, and Risks
The filing text does not include management commentary, future guidance, risk factors, contingencies, or details on unusual items. It strictly confirms the dissemination of the Half Year Report results.
Investor Verification Checklist
- Verify the specific financial results by accessing the Half Year Report advertisements on the company website (www.gsk.com).
- Confirm the availability of the full report at the UK Listing Authority's Document Viewing Facility in London.
- Review the original advertisements in the Financial Times, Daily Telegraph, and Wall Street Journal dated July 29, 2005, for detailed performance metrics.